Screening subtraction libraries from normal and type II diabetic human skeletal muscle, we identified four different mitochondrially encoded genes which were increased in expression in diabetes. The genes were cytochrome oxidase I, cytochrome oxidase III, NADH dehydrogenase IV, and 12s rRNA, all of which are located on the heavy strand of the mitochondrial genome. There was a 1.5-to 2.2-fold increase in the expression of these mRNA molecules relative to total RNA in both type I and type II diabetes as assessed by Northern blot analyses. Since there was approximately 50% decrease in mitochondrial DNA copy number as estimated by Southern blot analyses, mitochondrial gene expression increased approximately 2.5-fold when expressed relative to mitochondrial DNA copy number. For cytochrome oxidase I similar changes in mitochondrial gene expression were observed in muscle of nonobese diabetic and ob/ob mice, models of type I and type II diabetes, respectively. By contrast there was no change or a slight decrease in expression of cytochrome oxidase 7a, a nuclear-encoded subunit of cytochrome oxidase, and the expression of mitochondrial transcription factor 1 in human skeletal muscle did not change with type I or type II diabetes. The increased mitochondrial gene expression may contribute to the increase in mitochondrial respiration observed in uncontrolled diabetes. Abstract Screening subtraction libraries from normal and type II diabetic human skeletal muscle, we identified four different mitochondrially encoded genes which were increased in expression in diabetes. The genes were cytochrome oxidase I, cytochrome oxidase III, NADH dehydrogenase IV, and 12s rRNA, all of which are located on the heavy strand of the mitochondrial genome. There was a 1.5-to 2.2-fold increase in the expression of these mRNA molecules relative to total RNA in both type I and type II diabetes as assessed by Northern blot analyses. Since there was -50% decrease in mitochondrial DNA copy number as estimated by Southern blot analyses, mitochondrial gene expression increased -2.5-fold when expressed relative to mitochondrial DNA copy number. For cytochrome oxidase I similar changes in mitochondrial gene expression were observed in muscle of nonobese diabetic and ob/ob mice, models of type I and type II diabetes, respectively. By contrast there was no change or a slight decrease in expression of cytochrome oxidase 7a, a nuclear-encoded subunit of cytochrome oxidase, and the expression of mitochondrial transcription factor 1 in human skeletal muscle did not change with type I or type II diabetes. The increased mitochondrial gene expression may contribute to the increase in mitochondrial respiration observed in uncontrolled diabetes. (J. Clin. Invest. 1995. 95:1383-1388
Introduction
Mitochondria contain closed circular, double-stranded DNA of 16.5 kb. Both strands of the mitochondrial DNA are tran- [1] [2] [3] [4] . It is believed that as with nuclear-encoded genes, mitochondrial gene transcription is regulated through trans-acting factors binding cis elements, although only a limited number of the trans elements which control these processes have been identified. The only transcription factor which has been cloned is the nuclear-encoded mitochondrial transcription factor 1 (mtTFl) (5) . In addition, and as opposed to nuclear-encoded genes, mitochondrial-encoded gene expression may also be regulated by changes in mitochondrial DNA copy number. Both type I (insulin-dependent) and type II (non-insulindependent) diabetes mellitus are characterized by alterations in glucose, protein, and lipid metabolism in skeletal muscle (6, 7) . These alterations are the result of changes in gene expression, as well as posttranslational modifications of proteins. Insulin itself has been shown to regulate expression of a large number of genes (for reviews see Meisler and Howard [8] and O'Brien and Granner [9] ); however, relatively little is known about insulin or diabetes-regulated gene expression in skeletal muscle. In an effort to identify changes in gene expression which might contribute to the pathogenesis of this disease, we have screened subtraction libraries made from normal and type II diabetic muscle tissue (10) . This report details our identification of four mitochondrial-encoded genes whose expression was altered in diabetes, and our efforts to characterize the mechanisms responsible for the observed changes.
Methods
Screening nornal-enriched and diabetes-enriched libraries. Subtraction libraries were made using cDNA generated from human leg skeletal muscle RNA isolated from normal and type II diabetic patients undergoing amputation (10) . Individual clones in these subtraction libraries were grown in 96-well dishes and screened for differential regulation in diabetes as described by Kahn and Reynet ( 11 Subtracted probes were prepared from the normal-enriched and diabetic-enriched libraries using PCR followed by EcoRI digestion and a multiprime labeling reaction ( 11) . Free nucleotides were separated from the probes using Elutips (Schleicher and Schuell, Inc., Keene, NH). After a prehybridization of at least 3 h to reduce nonspecific binding, the dot blots were hybridized for at least 24 h with the labeled probes in 50% formamide, Sx SSC, 0.1% SDS, 5x Denhardt's plus 100 M.ig/ ml salmon sperm DNA, and 1 Mg/ml KpnI cut pBluescript (Stratagene, Inc.). One of the duplicate blots was hybridized with the normal-enriched library probe and the other duplicate blot was hybridized with the diabetic-enriched library probe. Equal counts of the normal-enriched and diabetic-enriched library probes were added (-1 x 106 cpm/ml). Prehybridization and hybridization were at 42°C. The blots were washed two times for 20 min each at room temperature with 2x SSC, 1% SDS, and one time for 20 min at 600C in 0.2x SSC, 1% SDS, and analyzed by autoradiography.
Characterization of clones. Clones of genes which were shown to be differentially regulated by the above screening method were grown in LB ampicillin media and purified using a plasmid purification system (QIAGEN, Chatsworth, CA). Sequencing was done using Sequenase Version 2.0 sequencing kit (United States Biochemical Corp., Cleveland, OH). The sequencing reaction products were separated on a 6% polyacrylamide gel (Sequagel; National Diagnostics, Inc., Atlanta, GA).
Patients. Mixed fiber type human muscle samples were obtained from patients undergoing amputation. The patients in the control, type I, and type II diabetic groups were both male and female of various ages.
Samples were taken from either gastrocnemius or quadracep muscle. No systematic change in GLUT4 mRNA levels were observed (Antonetti, D. A., C. Reynet, and C. R. Kahn, unpublished observations).
Northern blot analysis. Human leg, skeletal muscle RNA was isolated using RNAzol B (Biotecx Laboratories, Inc., Houston, TX). RNA was also isolated from nonobese diabetic (NOD) mice which were diabetic for -1 mo and from age-matched controls using Snap-o-Sol (Biotecx) and from experimentally induced diabetic rats using RNAzol B (Biotecx). Experimentally induced diabetic rats were obtained by one intraperitoneal streptozotocin (Sigma Chemical Co., St. Louis, MO) injection ( 100 mg/kg body wt in citrate buffer pH 4.5 ) and were studied 1 wk after injection. The RNA was separated by electrophoresis on formaldehyde-agarose gels and transferred to nylon membranes by blotting (12). Blots were hybridized in 50 mM Pipes (pH 6.5), 100 mM NaCl, 50 mM sodium phosphate, 1 mM EDTA, 5% SDS, and 100 jug/ ml salmon sperm DNA at 42°C after a prehybridization of at least 3 h. The blots were washed three times for 15 min each at 65°C in 5% SDS, 0.5x SSC and one time for 15 min at 65°C in 0.1% SDS, 0.2x SSC. The blots were analyzed either by autoradiography and densitometric scanning or by using a Phosphorimager (Molecular Dynamics, Inc., Sunnyvale, CA) and quantitated using Imagequant Software (Molecular Dynamics, Inc.). For all Northern blots using human RNA, a single sample from one normal individual was used as an internal control for normalization of the data. Nearly all blots used were stripped and reprobed with clones whose expression were unchanged in type I and type II diabetes to ensure equal loading of RNA samples.
Quantitation of mitochondrial DNA copy number. Total genomic DNA was isolated from leg skeletal muscle of normal, type I, and type II diabetic human patients undergoing amputation. Frozen tissue samples were crushed using a mortar and pestle cooled with liquid N2. For every 100 mg tissue, 1.2 ml of digestion buffer (100 mM NaCl, 10 mM Tris pH 7.5, 25 mM EDTA, 0.5% SDS, and freshly added 0.1 mg/ml proteinase K) was added. The samples were incubated with shaking at 50°C for 18 h. The samples were extracted twice with an equal volume of phenol/chloroform/isoamylalcohol ( temperature by adding 0.5 vol of 7.5 M ammonium acetate and 2 vol of ethanol. The strands of DNA were fished from solution using a glass pipette hook, rinsed in 70% ethanol, allowed to dry, and resuspended in Tris-EDTA. The concentration of DNA was determined spectrophotometrically. The DNA was digested with one of four enzymes: EcoRI, PstI, BamHI, or KpnI. Southern blot analyses were then performed essentially as described in Sambrook et al. (13), and the results were quantitated using a Phosphoimager and ImageQuant software. The value for each sample was normalized to one control patient as described above. Plasmids. Plasmid mtTFl was obtained from Dr. D. A. Clayton, Stanford University School of Medicine, Stanford, CA and contained nucleotides 259-873 of human mitochondrial transcription Factor 1 plus an additional 5' ATG in pBluescript II KS (+) (5). Plasmid pCox7aM.541 containing a 341-bp insert coding for the full-length human cytochrome oxidase Vlla-muscle isoform cDNA in vector pBSt was kindly provided by Dr. E. A. Schon, Columbia University College of Physicians and Surgeons, New York (14) .
Statistical analyses. For statistical analyses, a Student's t test was used with a two-tailed P value.
Results
Identifying clones from the subtraction libraries which are differentially expressed in diabetes. Subtraction libraries made from human skeletal muscle RNA were screened with subtracted probes to identify clones which encode genes differentially expressed in diabetes as described in Methods (10, 11) . The presumptive differentially expressed clones were then used as probes in Northem blot analyses of human skeletal muscle to determine more precisely the effect of type I and type II diabetes on expression of the genes encoded by the clones. Of over 5,000 clones screened, 19 were found to be differentially expressed in type I and/or type II diabetes. These clones were partially sequenced and compared to the data banks of known genes. Using these techniques, four mitochondrial-encoded genes were identified which were increased in expression in type I and type II diabetes. They are cytochrome oxidase I (Cox I), cytochrome oxidase III (Cox III), NADH dehydrogenase IV, and 12s rRNA. As compared to the nondiabetic, the expression of these clones was increased 1.55-to 1.94-fold at the RNA level ( Fig. 1 and Table I ). More extensive Northern blot analyses were done for the clones encoding Cox I, Cox III, and 12s rRNA ( Fig. 2 and Table I ). The expression of RNA for all of these genes was increased to a similar extent in both type I and type II diabetes as compared to normal. This increase was (Fig. 6 ).
Diabetes and c(tochrome oxidase 7ai muscle isofot(n ild mitochondrial transcription Factor I miuRNA exp7ression. To elucidate the molecular mechanism by which diabetes might regulate mitochondrial gene expression and mitochondrial DNA copy number, we examined the effect of diabetes on the mRNA level of the nuclear-encoded cytochrome oxidase subunit, cytochrome oxidase 7a muscle isoform (Cox 7aM) and the nuclearencoded mitochondrial transcription factor mtTFI. In human skeletal muscle the mRNA of Cox 7aM was not increased in diabetes. Fig. 7 is a representative result of four Northern or slot blot hybridization experiments in which no consistent change in mitochondriall DNA copy numlber in type I and type II diabetes was decreased relative to normal by 50%lc (Fig. 3, bottom) .
Thus, when expressed r-elative to mitochondrial DNA copy number, mitochondrial-enicoded gene expression was increased to a greater extenit than estimtated by Northern blot analysis (FFig. 4). For the four mitochondrially enicoded genes studied, expression relative to mitochondr-ial DNA was increased from 2.13-to 3.01-fold in type 11 diabetes aIs compared to normal (Table I ) .
Mitochoniitidal RNA evp/)-ecssiot in t anima0l m2odels of dia betes. The effect of diabetes oni Cox I and Cox III expression in skeletal musclc of NOD miice, a type I di(abetic animal model, was determined by Norther-ni blot ancalysis. As in humans with type I diabetes, the expressioni of Cox I imRNA increased 1.67-fold in the diabetic animlals as comnpar-ed to controls while Cox III expressioni increased 1.35-fold (Fig. 5 ). An increase of 1.4-fold in the expressioni ot Cox I mRNA was also observed in the skeletal muLscle of ob/ob mice. ai model of type II diabetes, relative to the control ob/ + mice ( Fig. 6 ) . Interestingly, skeletal muscle of r-ats with I wk of streptozotocin-iinduced type I diabe- (Fig. 7) .
Discussion
To identify changes in gene expression which might contribute to the pathogenesis of human diabetes mellitus, subtraction libraries made from normal and type II diabetic human skeletal muscle were screened using subtractive probes. Using this approach we identified four mitochondrial encoded genes: cytochrome oxidase I, cytochrome oxidase III, NADH dehydrogenase IV, and 12s rRNA, whose expression is increased in both type I and type II diabetes. This occurs despite a decrease in mitochondrial DNA copy number and with no change in the nuclear-encoded cytochrome oxidase VIIaM subunit or transacting factor mitochondrial transcription factor 1. All of the mitochondrial-encoded genes studied are located on the mitochondrial H-strand. The H-strand has two sites where transcription is initiated ( 16) . Initiation from one site yields a transcript of the entire heavy strand and is processed to the individual mRNAs, tRNAs, and rRNAs; initiation from the other site transcribes the rRNAs and a limited number of tRNAs. The fact that the three mRNAs and one rRNA increase in expression to a similar extent, suggests that the effect of diabetes on mitochondrial gene expression is mediated through complete heavy chain transcription. The effect of diabetes on light strand transcription was not studied. Previously, Williams et al. (17, 18) proposed that the major mechanism by which mitochondrial gene expression is regulated is through changes in mitochondrial DNA copy number. Changes in oxidative capacity of different skeletal muscle fiber types correlates with differences in mitochondrial DNA copy number ( 17) , and exercise-induced changes in oxidative capacity also correlates with changes in mitochondrial DNA copy number ( 17, 18 ) . In the present study, increased mitochondrial gene expression occurs under circumstances in which the mitochondrial DNA copy number is decreased. A similar discordance between mitochondrial gene regulation and DNA copy number has been reported by Van Itallie who found increased oxidative capacity in a hepatoma cell line after thyroid hormone addition and mitochondrial gene expression, but no change in mitochondrial DNA copy number (19).
All of the known trans elements controlling mitochondrial transcription and replication in humans are nuclear encoded. The transcription factor mtTFl binds both H-strand and light strand promoters, and its DNA binding has been correlated with the ability of in vitro extracts to initiate transcription (3). mtTFI may have multiple roles in initiation of DNA replication, both as a factor initiating primer transcription and as a factor involved in processing the primer (3). In diabetes, the change in mitochondrial gene expression is not regulated by a change in DNA copy number or by a change in expression of mtTF . However, it is possible that a posttranslational modification of mtTFl or the expression or modification of another trans-acting factor is involved in the regulation of mitochondrial gene expression in diabetes.
In this study we also measured the mRNA of a nuclearencoded mitochondrial enzyme Cox 7aM to determine if changes in nuclear-encoded mitochondrial genes are coordinated with changes in mitochondrial encoded genes. A number of the nuclear-encoded mitochondrial enzymes contain a binding site for nuclear regulatory factor 1 which may be involved in gene regulation. A binding site for nuclear regulatory factor 1 has also been identified in mitochondrial RNA processing RNA, a factor involved in mitochondrial DNA replication (20, 21) . Other cis elements common to mitochondrial genes have been identified (22) . We found that in diabetes, the level of Cox 7aM mRNA was unchanged or possibly slightly decreased. Again, this is similar to the effect of thyroid hormone in cell culture in that changes in mitochondrial DNA gene expression are not necessarily coordinated with changes in nuclear-encoded mitochondrial enzymes ( 19, 23, 24) . Increases in electron transport chain complexes may be achieved under such circumstances by a pool of unutilized nuclear-encoded subunits. For example, it has been proposed that mitochondrial-encoded Cox I regulates cytochrome c oxidase assembly and the nuclearencoded subunits are not limiting ( 19, 23, 25) .
There have been a number of case studies defining a link between point mutations (26, 27) , duplication (28) , and deletion (29) of mitochondrial genes with diabetes; (for review see Gerbitz [30] ). In all these cases, the patients have multisystem genetic disorder of which diabetes is only one component. To our knowledge, the only studies on mitochondrial gene expression in diabetes are those of Minchenko who found a decrease in mitochondrial gene expression in liver and heart of rats with experimentally induced diabetes which could be reversed by insulin treatment (31, 32 (33) and a 50% decrease in oxidative phosphorylation in skeletal muscle (34) . By contrast, human skeletal muscle mitochondria from well controlled diabetics show no change in oxidative phosphorylation, and in uncontrolled diabetes there is an increase in mitochondrial respiration by -1.50-fold (35) . This is in agreement with our finding of an increase in expression of mitochondrially encoded genes of the oxidative phosphorylation pathway. Furthermore, in rats with long-term alloxan or streptozotocin-induced diabetes, mitochondrial oxidative phosphorylation is increased -1.40-fold in liver (36) . In summary, diabetes mellitus increases skeletal muscle mitochondrial gene expression despite decreased mitochondrial DNA copy number. The effect of diabetes on mitochondrial gene expression is mediated by an as yet undefined mechanism, but does not appear to involve mtTFI expression. The change in mitochondrial gene expression could contribute to changes in oxidative phosphorylation observed in uncontrolled diabetes in humans and some diabetic animal models.
